definiens: shall mean, with respect to any SPC-3649 Product, the gross invoiced sales of SPC-3649 Product sold byGSK, its Affiliates or Sublicensees ( in each case, the ), in finished product form, packaged and lab eled for sale, under this Agreement in arm ’s length sales to Third Parties, less the following deductions which are actually in curred, allowed, paid, accrued or specifically allo cated to the Third Partycustomer by the Selling Party, to the extent actual ly taken by such Third Party customer, on such sale s for : ( a ) [ ... * * * ... ] trade, quantity, and cash discounts ; ( b ) [ ... * * * ... ] credi ts, rebates and chargebacks ( including those to [ .. . * * * ... ] including [ [ ... * * * ... ], and allowances or credits to customers on account o f [ ... * * * ... ] or on account of [ ... * * * ... ] affectin g such SPC-3649 Product;(c ) [ ... * * * ... ] charges relating to such SPC-3649 P roduct, including [ ... * * * ... ] thereto ; ( d ) [ ... * * * . .. ] directly linked to the sales ofsuch SPC-3649 Product to the extent included in the gross amount invoiced ; ( e ) the lesser or [ ... * * * .. . ] of Net Sales or [ ... * * * ... ] ; ( f ) [ ... * * * ... ] allowed or paid to [ .. . * * * ... ] employed by the Selling Party ; and ( g ) any other items actually deductedfrom gross invoiced sales amounts as reported by su ch Party in its financial statements in accordance with, in the case of GSK’sNet Sales, the International Financial Reporting St andards, applied on a consistent basis, and, in the case of Regulus ’ NetSales, the U.S. generally accepted accounting princ iples applied on a consistent basis